NBRV Executive Compensation
* In USD (Original Currency)
Filing Date (SEC Report) |
Year | Reporting Name | Salary | Bonus | Stock Award | Incentive Plan Compensation | Other Compensation | Total |
---|---|---|---|---|---|---|---|---|
2022-07-11 | 2021 | Theodore Schroeder Chief Executive Officer | 594,170 | 0 | 0 | 302,993 | 32,287 | 1,237,300 |
2022-07-11 | 2020 | Theodore Schroeder Chief Executive Officer | 576,800 | 0 | 0 | 242,256 | 31,759 | 1,654,570 |
2022-07-11 | 2021 | Steven Gelone President and Chief Operating Officer | 500,947 | 225,000 | 0 | 191,590 | 14,138 | 1,543,024 |
2022-07-11 | 2020 | Steven Gelone President and Chief Operating Officer | 486,300 | 0 | 0 | 153,185 | 12,675 | 1,154,516 |
2022-07-11 | 2021 | Daniel Dolan Chief Financial Officer | 271,250 | 0 | 0 | 93,500 | 26,690 | 501,440 |
2021-07-01 | 2019 | Theodore Schroeder Chief Executive Officer | 560,000 | 0 | 0 | 119,250 | 28,372 | 1,496,164 |
2021-07-01 | 2019 | Jennifer Schranz Former Chief Medical Officer | 436,200 | 0 | 0 | 151,200 | 33,450 | 982,155 |
2021-07-01 | 2020 | Jennifer Schranz Former Chief Medical Officer | 460,000 | 100,000 | 0 | 145,203 | 28,604 | 1,074,113 |
2021-07-01 | 2019 | Steven Gelone President and Chief Operating Officer | 472,100 | 0 | 0 | 181,420 | 13,976 | 1,178,280 |
2021-07-01 | 2020 | Steven Gelone President and Chief Operating Officer | 486,300 | 0 | 0 | 153,185 | 12,675 | 1,154,516 |
2021-07-01 | 2020 | Theodore Schroeder Chief Executive Officer | 576,800 | 0 | 0 | 242,256 | 31,759 | 1,654,570 |
2020-06-25 | 2019 | Theodore Schroeder Chief Executive Officer | 560,000 | 0 | 0 | 119,250 | 28,372 | 1,496,164 |
2020-06-25 | 2018 | Theodore Schroeder Chief Executive Officer | 220,360 | 0 | 0 | 0 | 20,380 | 2,509,340 |
2020-06-25 | 2019 | Jennifer Schranz | 436,200 | 0 | 0 | 151,200 | 33,450 | 982,155 |
2020-06-25 | 2019 | Steven Gelone President and Chief Operating Officer | 472,100 | 0 | 0 | 181,420 | 13,976 | 1,178,280 |
2020-06-25 | 2018 | Steven Gelone President and Chief Operating Officer | 426,104 | 0 | 0 | 126,822 | 15,116 | 1,340,035 |
2019-06-14 | 2017 | Steven Gelone President and Chief Operating Officer | 370,278 | 0 | 0 | 93,766 | 15,942 | 1,015,041 |
2019-06-14 | 2018 | Colin Broom Chief Executive Officer | 275,137 | 0 | 0 | 355,594 | 223,131 | 2,044,987 |
2019-06-14 | 2017 | Colin Broom Chief Executive Officer | 457,387 | 0 | 0 | 183,501 | 40,158 | 1,916,881 |
2019-06-14 | 2018 | Theodore Schroeder | 220,360 | 0 | 0 | 0 | 20,380 | 2,509,340 |
2019-06-14 | 2018 | Francesco Maria Lavino | 360,298 | 50,000 | 0 | 119,438 | 36,253 | 1,088,764 |
2019-06-14 | 2018 | Steven Gelone President and Chief Operating Officer | 426,104 | 0 | 0 | 126,822 | 15,116 | 1,340,035 |
2018-06-19 | 2017 | Steven Gelone | 370,278 | 0 | 0 | 93,766 | 15,942 | 1,015,041 |
2018-06-19 | 2017 | Gary Sender | 360,303 | 0 | 0 | 104,125 | 32,997 | 1,032,480 |
2018-06-19 | 2016 | Elyse Seltzer Chief Medical Officer | 365,022 | 0 | 0 | 106,505 | 23,735 | 780,241 |
2018-06-19 | 2017 | Elyse Seltzer Chief Medical Officer | 303,005 | 0 | 0 | 108,635 | 253,134 | 1,199,829 |
2018-06-19 | 2016 | Colin Broom Chief Executive Officer | 410,354 | 0 | 0 | 175,776 | 43,043 | 1,398,971 |
2018-06-19 | 2017 | Colin Broom Chief Executive Officer | 457,387 | 0 | 0 | 183,501 | 40,158 | 1,916,881 |
2017-08-18 | 2016 | Colin Broom Chief Executive Officer | 431,766 | 0 | 0 | 183,501 | 43,371 | 1,165,394 |
2017-08-18 | 2015 | Colin Broom Chief Executive Officer | 413,592 | 0 | 0 | 154,526 | 39,587 | 3,352,314 |
2017-08-18 | 2016 | Elyse Seltzer Chief Medical Officer | 365,160 | 0 | 0 | 108,365 | 0 | 661,125 |
2017-08-18 | 2015 | Elyse Seltzer Chief Medical Officer | 236,378 | 0 | 0 | 70,332 | 0 | 992,843 |
2017-08-18 | 2016 | Peter Wolf General Counsel | 323,200 | 0 | 0 | 96,152 | 25,866 | 632,818 |
2017-08-18 | 2015 | Peter Wolf General Counsel | 82,411 | 0 | 0 | 24,517 | 5,912 | 311,555 |
Disclaimer: The data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by our third party API www.financialmodellingprep.com, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore, Discounting Cash Flows Inc. doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Discounting Cash Flows Inc. or anyone involved with Discounting Cash Flows Inc. will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.